Phenazopyridine does not improve catheter discomfort following gynecologic surgery - 19/08/11
Résumé |
Objective |
We sought to determine if phenazopyridine improves pain in catheterized patients recovering from gynecologic surgery.
Study Design |
This trial randomized 240 adult women, who were undergoing gynecologic surgery and requiring an indwelling Foley catheter, to placebo or phenazopyridine hydrocholoride. Group assignment was masked by instillation of orange dye in the Foley bag of both groups. The primary outcome was the mean postoperative visual analog score (VAS). Secondary outcomes were pain medicine utilization and blinding efficacy.
Results |
In all, 219 patients received study medications (112 phenazopyridine and 107 placebo). There was no significant difference in demographics, procedure type, bladder VAS, overall VAS, and pain medication use. Only 25 of the 45 participants who responded guessed their group assignment correctly, suggesting adequate blinding.
Conclusion |
Postoperative VAS scores and pain medicine usage did not change with using routine phenazopyridine following gynecology surgery. Colored dye adequately masks visual side effects of phenazopyridine.
Le texte complet de cet article est disponible en PDF.Key words : bladder, blinding, catheter, gynecology, phenazopyridine
Plan
| DISCLOSURE: Dr Brubaker received an honorarium from Pfizer, New York, NY in 2009. |
|
| Reprints not available from the authors. |
|
| Cite this article as: Anderson C, Chimhanda M, Sloan J, et al. Phenazopyridine does not improve catheter discomfort following gynecologic surgery. Am J Obstet Gynecol 2011;204:267.e1-3. |
Vol 204 - N° 3
P. 267.e1-267.e3 - mars 2011 Retour au numéro
Article précédent
- Being too large for gestational age precedes childhood obesity in African Americans
- Shobha H. Mehta, Michael Kruger, Robert J. Sokol
- Symptom resolution after hysterectomy and alternative treatments for chronic pelvic pain: does depression make a difference?
- Lee A. Learman, Steven E. Gregorich, Michael Schembri, Alison Jacoby, Rebecca A. Jackson, Miriam Kuppermann
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?